Society and culture
Names
Esketamine is the generic name of the drug and its INN and BAN, while esketamine hydrochloride is its BANM. It is also known as S(+)-ketamine, (S)-ketamine, or (–)-ketamine ((-)[+] ketamine) as well as by its developmental code name JNJ-54135419.Esketamine is sold under the brand name Spravato for use as an antidepressant and the brand names Eskesia, Ketanest, Ketanest S, Ketanest-S, Keta-S for use as an anesthetic (veterinary), among others. Availability
Esketamine is marketed as an antidepressant in the United States; and as an anesthetic in the European Union. Legal status
Esketamine is a Schedule III controlled substance in the United States. References
External links
"Esketamine". Drug Information Portal. U.S. National Library of Medicine. "Esketamine hydrochloride". Drug Information Portal. U.S. National Library of Medicine.
Chronic local hypoxia (such as that occurring with overuse of contact lenses) or inflammation may lead to peripheral corneal vascularization, or pannus. Pannus may also develop in diseases of the corneal stem cells, such as aniridia. It is often resolved by peritomy. == References ==